Biocept (BIOC) Reports Q3 Loss of $0.57/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. LITE
8. NVT
9. BP
10. SPY

Go back to Biocept (BIOC) Reports Q3 Loss of $0.57/Share

Biocept Reports 2016 Third Quarter Financial Results

November 9, 2016 4:05 PM EST

SAN DIEGO, Nov. 9, 2016 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing proprietary liquid biopsy tests that provide clinically actionable information to physicians to improve cancer treatment, reports financial results for the three and nine months ended September 30, 2016, and provides an update on business progress. 

"In the third quarter, we continued to increase our test volume growth while improving collections on our billing activities, resulting in record quarterly revenues of more than $1 million,"... More